Patient Guide: A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 71 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04777357
Status: 🟢 Enrolling Now
Condition: Depression, Bipolar I Disorder
Phase: PHASE3

Where You Can Participate

This study is available at 71 locations across the country.

Top locations include:
  • • Bentonville, Arkansas
  • • Anaheim, California
  • • Beverly Hills, California
  • • And 68 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. - Join Clinical Trial NCTNCT04777357

How to Join This Clinical Trial - NCTNCT04777357

Learn how to participate in this PHASE3 trial studying an investigational therapy for Depression, Bipolar I Disorder. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Depression, Bipolar I Disorder. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Depression, Bipolar I Disorder
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04777357 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 71 locations. Find a study site near you:

Clinical Research Site

Bentonville, Arkansas 72712 - United States

Status: COMPLETED

Clinical Research Site

Anaheim, California 92805 - United States

Status: RECRUITING

Clinical Research Site

Beverly Hills, California 90212 - United States

Status: COMPLETED

Clinical Research Site

Culver City, California 90230-6632 - United States

Status: COMPLETED

Clinical Research Site

Garden Grove, California 92844 - United States

Status: RECRUITING

Clinical Research Site

Long Beach, California 90807 - United States

Status: COMPLETED

Clinical Research Site

Orange, California 92868-4203 - United States

Status: RECRUITING

Clinical Research Site

Orange, California 92868 - United States

Status: RECRUITING

Clinical Research Site

Rancho Cucamonga, California 91730 - United States

Status: COMPLETED

Clinical Research Site

San Diego, California 92103-8229 - United States

Status: COMPLETED

And 61 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Depression, Bipolar I Disorder:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships